In cervical cancer, immunohistochemical evaluation of E7 oncoprotein staining has been reported to be feasible [27] and might be a more adequate surrogate marker for HPV, as p16 is not exclusively increased by E7 oncoprotein in carcinogenesis. This evidence concerns the gene CDKN2A and cervical cancer.